Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A10887 | 31139863 | J Mol Med (Berl) | Skeletal muscle miR-34a/SIRT1:AMPK axis is activated in experimental and human non-alcoholic steatohepatitis. | 2019 | Details |
| A10888 | 31139087 | Front Physiol | Circadian Clock Genes in the Metabolism of Non-alcoholic Fatty Liver Disease. | 2019 | Details |
| A10889 | 31138858 | Sci Rep | Metabolic Characteristics of a Novel Ultrasound Quantitative Diagnostic Index for Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A10890 | 31138581 | BMJ Open | Western Australian pregnancy cohort (Raine) Study: Generation 1. | 2019 | Details |
| A10891 | 31137547 | Medicina (Kaunas) | Dietary and Pharmacological Treatment of Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A10892 | 31137047 | Planta Med | Z-ligustilide and n-Butylidenephthalide Isolated from the Aerial Parts of Angelica tenuissima Inhibit Lipid Accumulation In Vitro and In Vivo. | 2019 | Details |
| A10893 | 31136997 | Top Antivir Med | Fatty liver disease in persons with HIV infection. | 2019 | Details |
| A10894 | 31136662 | Am J Clin Nutr | Yogurt improves insulin resistance and liver fat in obese women with nonalcoholic fatty liver disease and metabolic syndrome: a randomized controlled trial. | 2019 | Details |
| A10895 | 31136656 | Am J Clin Nutr | Different acute effects of fructose and glucose administration on hepatic fat content. | 2019 | Details |
| A10896 | 31135632 | J Clin Gastroenterol | Increasing Clinical and Economic Burden of Nonalcoholic Fatty Liver Disease Among Hospitalized Adults in the United States. | 2020 | Details |
| A10897 | 31135513 | Eur J Gastroenterol Hepatol | Fibroscan and low-density lipoprotein as determinants of severe liver fibrosis in diabetic patients with nonalcoholic fatty liver disease. | 2019 | Details |
| A10899 | 31134516 | Curr Environ Health Rep | Mechanisms of Environmental Contributions to Fatty Liver Disease. | 2019 | Details |
| A10900 | 31134334 | J Gastroenterol | Nonalcoholic fatty liver disease is associated with lower hepatitis B viral load and antiviral response in pediatric population. | 2019 | Details |
| A10901 | 31132798 | Horm Metab Res | Association Between Visfatin and Hepatic Steatosis in the General Population During Long-Term Follow-Up. | 2019 | Details |
| A10902 | 31132328 | Chem Biol Interact | CYP3A suppression during diet-induced nonalcoholic fatty liver disease is independent of PXR regulation. | 2019 | Details |
| A10903 | 31132314 | J Gastroenterol Hepatol | Decrease in fat de novo synthesis and chemokine ligand expression in non-alcoholic fatty liver disease caused by inhibition of mixed lineage kinase domain-like pseudokinase. | 2019 | Details |
| A10904 | 31132306 | Scand J Immunol | Epoxyeicosatrienoic acids alleviate methionine-choline-deficient diet-induced non-alcoholic steatohepatitis in mice. | 2019 | Details |
| A10905 | 31131845 | Clin Infect Dis | Natural Course of Nonalcoholic Fatty Liver Disease and Type 2 Diabetes in Patients With Human Immunodeficiency Virus With and Without Combination Antiretroviral Therapy-associated Lipodystrophy: A 16-Year Follow-up Study. | 2020 | Details |
| A10906 | 31131357 | Ann Gastroenterol Surg | Improvement of non-alcoholic fatty liver disease after laparoscopic sleeve gastrectomy in Japanese obese patients. | 2019 | Details |
| A10907 | 31131153 | Am J Cardiovasc Dis | Ramipril significantly attenuates the development of non-alcoholic steatohepatitis in hyperlipidaemic rabbits. | 2019 | Details |
| A10908 | 31130652 | Metabolites | Non-Alcoholic Fatty Liver Disease, and the Underlying Altered Fatty Acid Metabolism, Reveals Brain Hypoperfusion and Contributes to the Cognitive Decline in APP/PS1 Mice. | 2019 | Details |
| A10910 | 31130411 | Ultrasound Med Biol | Considerations of Ultrasound Scanning Approaches in Non-alcoholic Fatty Liver Disease Assessment through Acoustic Structure Quantification. | 2019 | Details |
| A10911 | 31129048 | Biochem Pharmacol | A dual farnesoid X receptor/soluble epoxide hydrolase modulator treats non-alcoholic steatohepatitis in mice. | 2019 | Details |
| A10912 | 31128886 | J Pediatr | The Role of Genetic Predisposition, Programing During Fetal Life, Family Conditions, and Post-natal Diet in the Development of Pediatric Fatty Liver Disease. | 2019 | Details |
| A10913 | 31127561 | Methods Mol Biol | Application of Stable Isotope Labels for Metabolomics in Studies in Fatty Liver Disease. | 2019 | Details |
| A10914 | 31126802 | Hepatobiliary Pancreat Dis Int | miR-222 targets ACOX1, promotes triglyceride accumulation in hepatocytes. | 2019 | Details |
| A10915 | 31126574 | Complement Ther Med | Effect of soy milk consumption on glycemic status, blood pressure, fibrinogen and malondialdehyde in patients with non-alcoholic fatty liver disease: a randomized controlled trial. | 2019 | Details |
| A10916 | 31126557 | Complement Ther Med | Nigella sativa and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: Results from a randomized, double-blind, placebo-controlled, clinical trial. | 2019 | Details |
| A10917 | 31125357 | PLoS One | Adaptation of controlled attenuation parameter (CAP) measurement depth in morbidly obese patients addressed for bariatric surgery. | 2019 | Details |
| A10918 | 31124886 | J Pediatr Gastroenterol Nutr | Psychotropic Medications Are Associated With Increased Liver Disease Severity in Pediatric Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A10919 | 31124558 | Am J Clin Nutr | Gut microbiome-targeted therapies in nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression. | 2019 | Details |
| A10920 | 31123744 | Food Funct | Ellagic acid ameliorates AKT-driven hepatic steatosis in mice by suppressing de novo lipogenesis via the AKT/SREBP-1/FASN pathway. | 2019 | Details |
| A10921 | 31123622 | Liver Res | Autophagy in non-alcoholic fatty liver disease and alcoholic liver disease. | 2018 | Details |
| A10922 | 31123000 | BMJ Open | Healthcare practitioners' experiences of an intervention to detect and treat patients with liver disease (the LOCATE intervention): a qualitative process evaluation. | 2019 | Details |
| A10924 | 31120974 | PLoS One | Evaluation of rat liver with ARFI elastography: In vivo and ex vivo study. | 2019 | Details |
| A10925 | 31120519 | Transl Behav Med | Using the theoretical domains framework to identify barriers and enabling factors to implementation of guidance for the diagnosis and management of nonalcoholic fatty liver disease: a qualitative study. | 2020 | Details |
| A10926 | 31119399 | Eur J Nutr | Non-nutritive sweeteners and their association with the metabolic syndrome and non-alcoholic fatty liver disease: a review of the literature. | 2019 | Details |
| A10927 | 31119300 | Cell Mol Life Sci | Persistent changes in liver methylation and microbiome composition following reversal of diet-induced non-alcoholic-fatty liver disease. | 2019 | Details |
| A10928 | 31117231 | Nutrients | Transcriptome Analysis of Dual FXR and GPBAR1 Agonism in Rodent Model of NASH Reveals Modulation of Lipid Droplets Formation. | 2019 | Details |
| A10929 | 31116779 | PLoS One | A study on hepatopathic, dyslipidemic and immunogenic properties of fructosylated-HSA-AGE and binding of autoantibodies in sera of obese and overweight patients with fructosylated-HSA-AGE. | 2019 | Details |
| A10930 | 31115630 | Appl Microbiol Biotechnol | Lactobacillus plantarum NA136 improves the non-alcoholic fatty liver disease by modulating the AMPK/Nrf2 pathway. | 2019 | Details |
| A10931 | 31115369 | Indian J Med Res | Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: An increasing concern. | 2019 | Details |
| A10932 | 31115065 | J Gastroenterol Hepatol | Type 2 diabetes mellitus: A risk factor for progression of liver fibrosis in middle-aged patients with non-alcoholic fatty liver disease. | 2019 | Details |
| A10933 | 31114643 | World J Hepatol | Nonalcoholic fatty liver disease prevalence in an Italian cohort of patients with hidradenitis suppurativa: A multi-center retrospective analysis. | 2019 | Details |
| A10934 | 31114547 | Front Endocrinol (Lausanne) | Hepatic Gene Expression Profiles Differentiate Steatotic and Non-steatotic Grafts in Liver Transplant Recipients. | 2019 | Details |
| A10935 | 31114278 | Diabetes Metab Syndr Obes | Progressive reduction in skeletal muscle mass to visceral fat area ratio is associated with a worsening of the hepatic conditions of non-alcoholic fatty liver disease. | 2019 | Details |
| A10936 | 31114130 | World J Gastroenterol | Microbial metabolites in non-alcoholic fatty liver disease. | 2019 | Details |
| A10938 | 31113816 | J Lipid Res | Elevated oxysterol levels in human and mouse livers reflect nonalcoholic steatohepatitis. | 2019 | Details |
| A10939 | 31113613 | Ann Hepatol | Lysosomal Acid Lipase: Can it be a New Non-Invasive Serum Biomarker of Cryptogenic Liver Fibrosis and Cirrhosis? | 2020 | Details |
| A10940 | 31113580 | Ann Hepatol | miR-182-5p Attenuates High-Fat -Diet-Induced Nonalcoholic Steatohepatitis in Mice. | 2020 | Details |
| A10941 | 31113010 | Br J Pharmacol | Bouchardatine analogue alleviates non-alcoholic hepatic fatty liver disease/non-alcoholic steatohepatitis in high-fat fed mice by inhibiting ATP synthase activity. | 2019 | Details |
| A10942 | 31112805 | J Glob Antimicrob Resist | Refractory Helicobacter pylori gastritis: The hidden predictors of resistance. | 2019 | Details |
| A10943 | 31111657 | Obes Rev | The effects of oleoylethanolamide, an endogenous PPAR-α agonist, on risk factors for NAFLD: A systematic review. | 2019 | Details |
| A10944 | 31110956 | Pediatr Gastroenterol Hepatol Nutr | Association Between Vitamin D Deficiency and Suspected Nonalcoholic Fatty Liver Disease in an Adolescent Population. | 2019 | Details |
| A10945 | 31110049 | J Lipid Res | FTY720/fingolimod decreases hepatic steatosis and expression of fatty acid synthase in diet-induced nonalcoholic fatty liver disease in mice. | 2019 | Details |
| A10946 | 31109939 | Diabetes | The cGAS-cGAMP-STING Pathway: A Molecular Link Between Immunity and Metabolism. | 2019 | Details |
| A10947 | 31108934 | Nutrients | Dietary Carotenoids and Non-Alcoholic Fatty Liver Disease among US Adults, NHANES 2003⁻2014. | 2019 | Details |
| A10949 | 31107849 | Surg Laparosc Endosc Percutan Tech | The Effect of Laparoscopic Sleeve Gastrectomy on Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A10951 | 31106203 | Front Med (Lausanne) | The Patient Perspectives on Future Therapeutic Options in NASH and Patient Needs. | 2019 | Details |
| A10952 | 31105592 | Front Physiol | Tangshen Formula Alleviates Hepatic Steatosis by Inducing Autophagy Through the AMPK/SIRT1 Pathway. | 2019 | Details |
| A10953 | 31105018 | Ann Hepatol | "Hepatic toxicity by methotrexate with weekly single doses associated with folic acid in rheumatoid and psoriatic arthritis. What is its real frequency?" | 2019 | Details |
| A10955 | 31104631 | BMC Med | Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts. | 2019 | Details |
| A10956 | 31104523 | Expert Rev Gastroenterol Hepatol | A critical appraisal of the use of ultrasound in hepatic steatosis. | 2019 | Details |
| A10957 | 31104052 | Obes Facts | SCCA-IgM as a Potential Biomarker of Non-Alcoholic Fatty Liver Disease in Patients with Obesity, Prediabetes and Diabetes Undergoing Sleeve Gastrectomy. | 2019 | Details |
| A10958 | 31103458 | Ann Hepatol | Low serum vitamin D is independently associated with unexplained elevated ALT only among non-obese men in the general population. | 2019 | Details |
| A10959 | 31102719 | J Hepatol | New sequential combinations of non-invasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD. | 2019 | Details |
| A10960 | 31101783 | Georgian Med News | RESULTS OF CORRECTION OF THE HEPATIC STEATOSIS ON THE BACKGROUND OF HYPERTENSION AND OVERWEIGHT WITH HELP OF ESSENTIAL PHOSPHOLIPID COMPLEX. | 2019 | Details |
| A10961 | 31101782 | Georgian Med News | COMPARATIVE ANALYSIS OF EFFICIENCY OF URSODEOXYCHOLIC ACID AND COMBINATION OF VITAMIN E AND VITAMIN C IN TREATMENT OF NON-DIABETIC NONALCOHOLIC STEATOHEPATITIS. | 2019 | Details |
| A10962 | 31101468 | Rev Gastroenterol Mex (Engl Ed) | Efficacy of dietary intervention and physical activity in children and adolescents with nonalcoholic fatty liver disease associated with obesity: A scoping review. | 2019 | Details |
| A10963 | 31101239 | Arch Med Res | Intestinal Trefoil Factor 3 Alleviates the Intestinal Barrier Function Through Reducing the Expression of TLR4 in Rats with Nonalcoholic Steatohepatitis. | 2019 | Details |
| A10964 | 31101130 | Lipids Health Dis | The effect of bergamot polyphenolic fraction on lipid transfer protein system and vascular oxidative stress in a rat model of hyperlipemia. | 2019 | Details |
| A10965 | 31100570 | Environ Pollut | Sodium perchlorate induces non-alcoholic fatty liver disease in developing stickleback. | 2019 | Details |
| A10966 | 31100460 | Clin Gastroenterol Hepatol | Liver Stiffness Severity is Associated With Increased Cardiovascular Risk in Patients With Type 2 Diabetes. | 2019 | Details |
| A10967 | 31099410 | Aliment Pharmacol Ther | Non-alcoholic steatohepatitis, but not simple steatosis, disturbs the functional homogeneity of the liver - a human galactose positron emission tomography study. | 2019 | Details |
| A10969 | 31098621 | Endocr Rev | The Liver as an Endocrine Organ-Linking NAFLD and Insulin Resistance. | 2019 | Details |
| A10972 | 31097771 | Sci Rep | The Differential Expression of Cide Family Members is Associated with Nafld Progression from Steatosis to Steatohepatitis. | 2019 | Details |
| A10973 | 31097179 | Maturitas | Nonalcoholic fatty liver disease in the over-60s: Impact of sarcopenia and obesity. | 2019 | Details |
| A10974 | 31096638 | Cells | Bone Morphogenetic Protein-8B Expression is Induced in Steatotic Hepatocytes and Promotes Hepatic Steatosis and Inflammation In Vitro. | 2019 | Details |
| A10975 | 31095863 | Mol Nutr Food Res | Trimethylamine N-Oxide Aggravates Liver Steatosis through Modulation of Bile Acid Metabolism and Inhibition of Farnesoid X Receptor Signaling in Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A10976 | 31094472 | Ter Arkh | Biochemical and molecular-genetic indicators of inflammation and apoptosis in liver cirrhosis as an outcome of the progression of non-alcoholic steatohepatitis. | 2019 | Details |
| A10977 | 31094185 | Ter Arkh | Role of intestinal microbiota in the formation of non-alcoholic fatty liver disease. | 2019 | Details |
| A10978 | 31094181 | Ter Arkh | Non-alcoholic fatty liver disease as a cause and consequence of cardio-metabolic complications. Role of the ursodeoxicholic acid in the pharmacotherapy. | 2019 | Details |
| A10979 | 31094171 | Ter Arkh | Comparative analysis of bile acid spectrum in non-alcoholic fatty liver disease and cholelithiasis. | 2019 | Details |
| A10980 | 31094076 | Obesity (Silver Spring) | Sub-phenotyping Metabolic Disorders Using Body Composition: An Individualized, Nonparametric Approach Utilizing Large Data Sets. | 2019 | Details |
| A10981 | 31094016 | Aliment Pharmacol Ther | Moderate to severe hepatic steatosis leads to overestimation of liver stiffness measurement in chronic hepatitis B patients without significant fibrosis. | 2019 | Details |
| A10982 | 31093446 | Food Sci Biotechnol | Green satsuma mandarin orange (Citrus unshiu) extract reduces adiposity and induces uncoupling protein expression in skeletal muscle of obese mice. | 2018 | Details |
| A10983 | 31092797 | J Oleo Sci | Hepatoprotective Effect of Seed Coat ofEuryale ferox Extract in Non-alcoholic Fatty Liver Disease Induced by High-fat Diet in Mice by Increasing IRs-1 and Inhibiting CYP2E1. | 2019 | Details |
| A10984 | 31092057 | Expert Rev Gastroenterol Hepatol | Association between non-alcoholic fatty liver disease and colorectal cancer. | 2019 | Details |
| A10985 | 31090336 | Zhongguo Zhong Yao Za Zhi | [Analysis on mechanisms and medication rules of herbal prescriptions for nonalcoholic fatty liver disease based on methods of data mining and biological information]. | 2019 | Details |
| A10986 | 31090267 | J Zhejiang Univ Sci B | Bile-ology: from bench to bedside. | 2019 | Details |
| A10987 | 31090041 | Curr Environ Health Rep | Understanding Environmental Contaminants' Direct Effects on Non-alcoholic Fatty Liver Disease Progression. | 2019 | Details |
| A10988 | 31089602 | Food Funct | A sulfated polysaccharide from Gracilaria Lemaneiformis regulates cholesterol and bile acid metabolism in high-fat diet mice. | 2019 | Details |
| A10989 | 31089576 | J Obes Metab Syndr | The Effects of Hypoglycemic Agents on Non-alcoholic Fatty Liver Disease: Focused on Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists. | 2019 | Details |
| A10990 | 31089474 | J Diabetes Res | Diabetes Mellitus, Nonalcoholic Fatty Liver Disease, and Conjugated Linoleic Acid (Omega 6): What Is the Link? | 2019 | Details |
| A10991 | 31089410 | Oxid Med Cell Longev | Higd1a Protects Cells from Lipotoxicity under High-Fat Exposure. | 2019 | Details |
| A10992 | 31089384 | Iran J Pharm Res | Reduction of Some Atherogenic Indices in Patients with Non-Alcoholic Fatty Liver by Vitamin D and Calcium Co-Supplementation: A Double Blind Randomized Controlled Clinical Trial. | 2019 | Details |
| A10993 | 31088856 | Diabetes | Liver Function and Risk of Type 2 Diabetes: Bidirectional Mendelian Randomization Study. | 2019 | Details |
| A10994 | 31087761 | IUBMB Life | Downregulation of hedgehog ligands in human simple steatosis may protect against nonalcoholic steatohepatitis: Is TAZ a crucial regulator? | 2019 | Details |
| A10995 | 31087530 | Physiol Rep | Whole-body vibration for patients with nonalcoholic fatty liver disease: a 6-month prospective study. | 2019 | Details |
| A10996 | 31086990 | Toxicol Sci | Gene Expression and DNA Methylation Alterations in the Glycine N-Methyltransferase Gene in Diet-Induced Nonalcoholic Fatty Liver Disease-Associated Carcinogenesis. | 2019 | Details |